Amplify 2.0

Journal

Engineering and Infrastructure

Portfolio Spotlight

Eliminating drug toxicity with AI: our investment in Axiom

Axiom is going to completely transform the multi-billion dollar market for drug toxicity testing.

Eliminating drug toxicity with AI: our investment in Axiom

Welcoming mabl to the Amplify family

Second Wave DevOps and Our Investment in System Initiative

Our Series A Investment in Sym

More Journal

Announcing $900M in new capital, our first digital biology fund, and our new look

Amplify Bio Manifesto

The agent-first developer toolchain: how AI will radically transform the SDLC

Eliminating drug toxicity with AI: our investment in Axiom

What gets to the front page of Hacker News?

What are SAFEs and convertible notes, and how do they differ?

What are 83(b) elections and why are they important?

Welcoming Our Newest Partner, Grace Ge